OBD — Oxford Biodynamics Balance Sheet
0.000.00%
- £11.80m
- £15.52m
- £1.10m
Annual balance sheet for Oxford Biodynamics, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.34 | 0.999 | 5.25 | 2.83 | 1.39 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.71 | 1.08 | 1.05 | 1.26 | 0.694 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 6.68 | 2.77 | 7.17 | 5.05 | 2.28 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.55 | 6.98 | 7 | 5.71 | 4.7 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 15.4 | 11.3 | 16.1 | 12.1 | 8.09 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.29 | 2.91 | 4 | 2.56 | 2.61 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.7 | 8.76 | 10.1 | 7.75 | 6.97 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 6.68 | 2.59 | 6.05 | 4.36 | 1.12 |
| Total Liabilities & Shareholders' Equity | 15.4 | 11.3 | 16.1 | 12.1 | 8.09 |
| Total Common Shares Outstanding |